Higher FDX1 expression is associated with better disease-free survival (DFS) and overall survival (OS) in renal cancer, liver hepatocellular carcinoma, LUAD, and lung squamous cell carcinoma [14]. This evidence concerns the gene FDX1 and squamous cell lung carcinoma.